Verily (Alphabet’s Division) Holds its Smart Lens Project

 Verily (Alphabet’s Division) Holds its Smart Lens Project

Verily (Alphabet’s Division) Holds its Smart Lens Project

Shots:

  • The hold of the project is in response to the insufficient consistency in measurements between tear glucose and blood glucose levels for evaluation of device
  • Glucose-Detecting Contact Lens was being developed to monitor the glucose levels in tears with help of sensors present in contact lens, which can further help to manage glucose level in blood
  • In 2014, Verily collaborated with Alcon (Novartis Division) for the development of contact lens and has also received $800M from Singapore investor Temasek in 2017

Click here to read full press release/ article | Ref: Reuters | Image: Axios

Shiwani Sharma

Shiwani Sharma was Senior Editor at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post